PubMed

Effects of sibutramine treatment in obese adolescents: a randomized trial.

Berkowitz RI, Fujioka K, Daniels SR, Hoppin AG, Owen S, Perry AC, Sothern MS, Renz CL, Pirner MA, Walch JK, Jasinsky O, Hewkin AC, Blakesley VA; Sibutramine Adolescent Study Group.

Ann Intern Med. 2006 Jul 18;145(2):81-90.PMID: 16847290 [PubMed - indexed for MEDLINE]Related articlesFree article

Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.

García-Morales LM, Berber A, Macias-Lara CC, Lucio-Ortiz C, Del-Rio-Navarro BE, Dorantes-Alvárez LM.

Clin Ther. 2006 May;28(5):770-82.PMID: 16861099 [PubMed - indexed for MEDLINE]Related articles

Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial.

Berkowitz RI, Wadden TA, Tershakovec AM, Cronquist JL.

JAMA. 2003 Apr 9;289(14):1805-12.PMID: 12684359 [PubMed - indexed for MEDLINE]Related articlesFree article

[Pharmacological therapy of obesity]

Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian. PMID: 18773755 [PubMed - indexed for MEDLINE]Related articles

Weight loss in obese African American and Caucasian adolescents: secondary analysis of a randomized clinical trial of behavioral therapy plus sibutramine.

Budd GM, Hayman LL, Crump E, Pollydore C, Hawley KD, Cronquist JL, Berkowitz RI.

J Cardiovasc Nurs. 2007 Jul-Aug;22(4):288-96.PMID: 17589281 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial.

McMahon FG, Fujioka K, Singh BN, Mendel CM, Rowe E, Rolston K, Johnson F, Mooradian AD.

Arch Intern Med. 2000 Jul 24;160(14):2185-91.PMID: 10904462 [PubMed - indexed for MEDLINE]Related articlesFree article

Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.

Sánchez-Reyes L, Fanghänel G, Yamamoto J, Martínez-Rivas L, Campos-Franco E, Berber A.

Clin Ther. 2004 Sep;26(9):1427-35.PMID: 15531005 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular effects of sibutramine in the treatment of obese adolescents: results of a randomized, double-blind, placebo-controlled study.

Daniels SR, Long B, Crow S, Styne D, Sothern M, Vargas-Rodriguez I, Harris L, Walch J, Jasinsky O, Cwik K, Hewkin A, Blakesley V; Sibutramine Adolescent Study Group.

Pediatrics. 2007 Jul;120(1):e147-57. Epub 2007 Jun 18.PMID: 17576783 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term weight loss with sibutramine: a randomized controlled trial.

Wirth A, Krause J.

JAMA. 2001 Sep 19;286(11):1331-9.PMID: 11560538 [PubMed - indexed for MEDLINE]Related articlesFree article

Randomized placebo-controlled trial of long-term treatment with sibutramine in mild to moderate obesity.

Smith IG, Goulder MA; Sibutramine Clinical Study 1047 Team.

J Fam Pract. 2001 Jun;50(6):505-12.PMID: 11407998 [PubMed - indexed for MEDLINE]Related articles

Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.

McMahon FG, Weinstein SP, Rowe E, Ernst KR, Johnson F, Fujioka K; Sibutramine in Hypertensives Clinical Study Group.

J Hum Hypertens. 2002 Jan;16(1):5-11.PMID: 11840224 [PubMed - indexed for MEDLINE]Related articlesFree article

Second phase of a double-blind study clinical trial on Sibutramine for the treatment of patients suffering essential obesity: 6 months after treatment cross-over.

Fanghänel G, Cortinas L, Sánchez-Reyes L, Berber A.

Int J Obes Relat Metab Disord. 2001 May;25(5):741-7.PMID: 11360159 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.

Sramek JJ, Leibowitz MT, Weinstein SP, Rowe ED, Mendel CM, Levy B, McMahon FG, Mullican WS, Toth PD, Cutler NR.

J Hum Hypertens. 2002 Jan;16(1):13-9.PMID: 11840225 [PubMed - indexed for MEDLINE]Related articlesFree article

A clinical trial of the use of sibutramine for the treatment of patients suffering essential obesity.

Fanghänel G, Cortinas L, Sánchez-Reyes L, Berber A.

Int J Obes Relat Metab Disord. 2000 Feb;24(2):144-50.PMID: 10702763 [PubMed - indexed for MEDLINE]Related articles

Evaluation of efficacy, reliability, and tolerability of sibutramine in obese patients, with an echocardiographic study.

Halpern A, Leite CC, Herszkowicz N, Barbato A, Costa AP.

Rev Hosp Clin Fac Med Sao Paulo. 2002 May-Jun;57(3):98-102.PMID: 12118266 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study.

Mathus-Vliegen EM; Balance Study Group.

Eur J Clin Nutr. 2005 Aug;59 Suppl 1:S31-8; discussion S39.PMID: 16052193 [PubMed - indexed for MEDLINE]Related articles

The effect of sibutramine on energy expenditure and body composition in obese adolescents.

Van Mil EG, Westerterp KR, Kester AD, Delemarre-van de Waal HA, Gerver WJ, Saris WH.

J Clin Endocrinol Metab. 2007 Apr;92(4):1409-14. Epub 2007 Jan 30.PMID: 17264187 [PubMed - indexed for MEDLINE]Related articlesFree article

Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus.

Fujioka K, Seaton TB, Rowe E, Jelinek CA, Raskin P, Lebovitz HE, Weinstein SP; Sibutramine/Diabetes Clinical Study Group.

Diabetes Obes Metab. 2000 Jun;2(3):175-87.PMID: 11220553 [PubMed - indexed for MEDLINE]Related articles

Six-month treatment of obesity with sibutramine 15 mg; a double-blind, placebo-controlled monocenter clinical trial in a Hispanic population.

Cuellar GE, Ruiz AM, Monsalve MC, Berber A.

Obes Res. 2000 Jan;8(1):71-82.PMID: 10678261 [PubMed - indexed for MEDLINE]Related articles

Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study.

Finer N, Bloom SR, Frost GS, Banks LM, Griffiths J.

Diabetes Obes Metab. 2000 Apr;2(2):105-12.PMID: 11220522 [PubMed - indexed for MEDLINE]Related articles